Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Juvenile Justice Girls Randomized Control Trial: Young Adult Follow-up

23 febbraio 2022 aggiornato da: Leslie D. Leve, Oregon Social Learning Center

Juvenile Justice Girls: Pathways to Adjustment and System Use in Young Adulthood

This study is a young adult follow-up of 166 females who originally participated in an RCT during adolescence due to their involvement in the juvenile justice system.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Females under age 18 years old are the fastest-growing segment of the juvenile justice population and are at risk for negative co-occurring outcomes including drug abuse, HIV/STI risk, criminal behavior, and educational failure. As they enter young adulthood, this constellation of behaviors puts them at heightened risk for early parenthood and subsequent involvement in the child welfare system (for their parenting behaviors) and the adult corrections system (for criminal behaviors). Such system involvement is costly, and its prevention would be of great significance to public health; however, very little is known about factors leading to females' success/failure in young adulthood and factors that might prevent involvement in these two public systems. This study aims to further our understanding of the pathways to and the prevention of HIV/STI risk, drug use, and child welfare and adult corrections involvement by following-up 166 women who participated in two randomized intervention trials aimed at reducing delinquency during adolescence. In the original studies, juvenile justice girls who had been referred for out-of-home placement due to chronic delinquency were randomly assigned to services as usual or to Treatment Foster Care Oregon (TFCO, formerly known as MTFC). Efficacy of the intervention with this sample has been shown at 12- and 24-month follow-ups on criminal referral rates, days spent in locked settings, deviant peer associations, educational engagement, and pregnancy prevention. The investigators propose to examine the developmental pathways for these juvenile justice girls into young adulthood (ages 21-28 years) using innovative data collection and data analytic techniques, with foci on the long-term effects of TFCO, the mediators of young adult adjustment and child welfare/corrections involvement, and the cost effectiveness and cost avoidance of TFCO on these outcomes. The overarching aim is to identify potential targets for subsequent intervention. One in-person assessment is proposed with each female and her current romantic partner (if she has one); in addition, telephone interviews will be conducted every 6 months for the duration of the study, and system data from child welfare and adult corrections will be collected.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

166

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

  • Stati Uniti
    • Oregon
      • Eugene, Oregon, Stati Uniti, 97401
        • Oregon Social Learning Center
      • Eugene, Oregon, Stati Uniti, 97403
        • University of Oregon

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 13 anni a 18 anni (Bambino, Adulto)

Accetta volontari sani

No

Sessi ammissibili allo studio

Femmina

Descrizione

Inclusion Criteria:

  • female
  • 13-17 years old
  • at least one criminal referral in the prior year
  • court-mandated placement in out-of-home care

Exclusion Criteria:

  • Currently pregnant

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Treatment Foster Care Oregon (TFCO)
Youth are placed individually in well-trained and supervised foster homes. Basic components include: (a) daily telephone contact with TFCO parents using the Parent Daily Report; (b) weekly foster parent group meetings focused on supervision, training in parenting practices, and support; (c) an individualized behavior management program implemented daily in the home by foster parent; (d) individualized skills training for the youth; (e) family therapy for aftercare family focused on parent management strategies; (f) close monitoring of school attendance, performance, and homework completion; (g) case management to coordinate TFCO, family, peer, and school settings; (h) 24-hour on-call staff availability to TFCO and biological parents; and (i) psychiatric consultation.
Comportamentale: Treatment Foster Care (TFCO)
Youth placed individually in well-trained and supervised foster homes. Basic components: (a) daily telephone contact with TFCO parents; (b) weekly foster parent group meetings focused on supervision, training in parenting practices, and support; (c) an individualized behavior management program implemented daily in the home by foster parent; (d) individualized skills training for the youth; (e) family therapy for aftercare family focused on parent management strategies; (f) close monitoring of school attendance, performance, and homework completion; (g) case management to coordinate TFCO, family, peer, and school settings; (h) 24-hour on-call staff availability to TFCO and biological parents; and (i) psychiatric consultation. Services typically last approximately 6 months.
Altri nomi:
  • Multidimensional Treatment Foster Care
Comparatore attivo: Group Care
Group Care is the usual service for youth placed in out-of-home care for chronic delinquency in Oregon. These programs represented typical services for girls being referred to out-of-home care by the juvenile justice system and had 2-51 youth in residence (M = 21) and 1-50 staff members (Mdn = 2); most also had onsite schooling. Although the programs differed somewhat in theoretical orientations, 86% reported that they endorsed a specific treatment model, of which the primary philosophy was a behavioral (70%), eclectic (26%), or family-style therapeutic approach (4%).
Comportamentale: Group Care
Group Care is the usual service for youth placed in out-of-home care for chronic delinquency in Oregon. These programs represented typical services for girls being referred to out-of-home care by the juvenile justice system and had 2-51 youth in residence (M = 21) and 1-50 staff members (Mdn = 2); most also had onsite schooling. Although the programs differed somewhat in theoretical orientations, 86% reported that they endorsed a specific treatment model, of which the primary philosophy was a behavioral (70%), eclectic (26%), or family-style therapeutic approach (4%). Services typically last approximately 6 months.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Delinquency
Lasso di tempo: Months 12, 24, 36, and young adulthood (ave. of 7 year follow-up + 10 year follow-up)
Measured as self-reported criminal activity and count of official arrests and criminal referrals
Months 12, 24, 36, and young adulthood (ave. of 7 year follow-up + 10 year follow-up)
substance use
Lasso di tempo: Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up + 10 year follow-up)
Measured via self-reported use and diagnostic interview assessment
Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up + 10 year follow-up)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
HIV risk behavior
Lasso di tempo: Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up)
Measured as self-reported engagement in sexual behaviors
Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up)
economic costs
Lasso di tempo: young adulthood (age 18-28; average of 7-year follow-up)
Measured by comparing the costs of intervention delivery relative to the two intervention programs relative to costs incurred through time in detention, jail, and prison; relative to costs incurred due to child welfare involvement; and relative to symptom counts on self-report inventories.
young adulthood (age 18-28; average of 7-year follow-up)
Depression
Lasso di tempo: Months 6, 12, 18, 24 and Young Adult (average 7 year follow-up)
Measured on the CESD depression inventory and the Brief Symptom Inventory, and via diagnostic interview
Months 6, 12, 18, 24 and Young Adult (average 7 year follow-up)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Oregon Social Learning Center

Collaboratori

National Institute on Drug Abuse (NIDA)
University of Oregon
National Institute of Mental Health (NIMH)

Investigatori

  • Investigatore principale: Leslie Leve, PhD, University of Oregon

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio

1 gennaio 1997

Completamento primario (Effettivo)

1 dicembre 2016

Completamento dello studio (Effettivo)

1 dicembre 2016

Date di iscrizione allo studio

Primo inviato

6 aprile 2011

Primo inviato che soddisfa i criteri di controllo qualità

22 aprile 2011

Primo Inserito (Stima)

26 aprile 2011

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

11 marzo 2022

Ultimo aggiornamento inviato che soddisfa i criteri QC

23 febbraio 2022

Ultimo verificato

1 febbraio 2022

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Altri numeri di identificazione dello studio

  • R01DA024672 (Sovvenzione/contratto NIH degli Stati Uniti)
  • R01DA015208 (Sovvenzione/contratto NIH degli Stati Uniti)
  • R01MH054257-01 (Sovvenzione/contratto NIH degli Stati Uniti)
  • R03MH091611 (Sovvenzione/contratto NIH degli Stati Uniti)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

Indeciso

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi